{rfName}
RH

Indexed in

License and use

Altmetrics

Grant support

The work was supported by Cancer Research UK (CRUK) C33043/A24478 (to V.S.-M., E.C.-M., O.M., and L.K.) ; Barts Charity (to V.S.M., R.S., and S.L.G.) ; The Harry J. Lloyd Charitable Trust (to J.L.O. and V.S.-M) ; and Comunidad de Madrid (Atracci?on de Talento-2019-T1/BMD-13642) (to J.L.O.) .

Analysis of institutional authors

Orgaz, JlAuthor
Share
Publications
>
Review

RHO GTPase SIGNALING IN CANCER PROGRESSION AND DISSEMINATION

Publicated to:PHYSIOLOGICAL REVIEWS. 102 (1): 455-510 - 2022-01-01 102(1), DOI: 10.1152/physrev.00045.2020

Authors: Crosas-Molist, Eva; Samain, Remi; Kohlhammer, Leonie; Orgaz, Jose L.; George, Samantha L.; Maiques, Oscar; Barcelo, Jaume; Sanz-Moreno, Victoria;

Affiliations

Queen Mary Univ London, Barts Canc Inst, London, England - Author
Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Madrid, Spain - Author

Abstract

Rho GTPases are a family of small G proteins that regulate a wide array of cellular processes related to their key roles controlling the cytoskeleton. Cancer is a multistep disease caused by the accumulation of genetic mutations and epigenetic alterations, from the initial stages of cancer development when cells in normal tissues undergo transformation, to the acquisition of invasive and metastatic traits, responsible for a large number of cancer related deaths. In this review, we discuss the role of Rho GTPase signaling in cancer in every step of disease progression. Rho GTPases contribute to tumor initiation and progression, by regulating proliferation and apoptosis, but also metabolism, senescence, and cancer cell sternness. Rho GTPases play a major role in cell migration and in the metastatic process. They are also involved in interactions with the tumor microenvironment and regulate inflammation, contributing to cancer progression. After years of intensive research, we highlight the importance of relevant models in the Rho GTPase field, and we reflect on the therapeutic opportunities arising for cancer patients.

Keywords
cancerclinical opportunitiesrho gtpasesAgc kinase inhibitorAnchorage-independent growthAnimalAnimalsBinding protein rhoBreast carcinomaCancerCancer growthCarcinogenesisCell motionCell movementCell transformationCell transformation, neoplasticClinical opportunitiesCollective cell-migrationColorectal cancerEndometrium carcinomaEpithelial-mesenchymal transitionFibroblastG protein coupled receptorGeneticsGlioblastomaHead and neck squamous cell carcinomaHumanHumansImmunologyKeratinocyteLeukemia-associated rhoLiver cell carcinomaLung adenocarcinomaMammalian target of rapamycinMelanomaMetabolismNeoplasmNeoplasmsNf-kappa-bNonhumanNucleotide exchange factorOvary carcinomaPancreas adenocarcinomaPhosphatidylinositol 3 kinasePhysiologyProstate adenocarcinomaProtein kinaseReviewRho gtp-binding proteinsRho gtpasesRho guanine nucleotide binding proteinSerum response elementSignal transductionSignalingSmall-molecule inhibitorSquamous cell carcinomaStomach cancerThyroid carcinomaTransitional cell carcinomaTumor microenvironment

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal PHYSIOLOGICAL REVIEWS due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 1/79, thus managing to position itself as a Q1 (Primer Cuartil), in the category Physiology. Notably, the journal is positioned above the 90th percentile.

This publication has been distinguished as a “Highly Cited Paper” by the agencies WoS (ESI, Clarivate) and ESI (Clarivate), meaning that it ranks within the top 1% of the most cited articles in its thematic field during the year of its publication. In terms of the observed impact of the contribution, this work is considered one of the most influential worldwide, as it is recognized as highly cited. (source consulted: ESI Nov 14, 2024)

And this is evidenced by the extremely high normalized impacts through some of the main indicators of this type, which, although dynamic over time and dependent on the set of average global citations at the time of calculation, already indicate that they are well above the average in different agencies:

  • Normalization of citations relative to the expected citation rate (ESI) by the Clarivate agency: 41.26 (source consulted: ESI Nov 14, 2024)
  • Weighted Average of Normalized Impact by the Scopus agency: 25.52 (source consulted: FECYT Feb 2024)
  • Field Citation Ratio (FCR) from Dimensions: 45 (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-19, the following number of citations:

  • WoS: 111
  • Scopus: 148
  • OpenCitations: 126
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-19:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 186.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 185 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 32.25.
  • The number of mentions on the social network X (formerly Twitter): 35 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Leadership analysis of institutional authors

This work has been carried out with international collaboration, specifically with researchers from: United Kingdom.